Regnum Corp. (RGMP)
0.0000
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.00 |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 0.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 100.00% |
Profile
| Regnum Corp. engages in the business of developing and commercializing therapeutics that treat rare and infectious diseases. It focuses on populations that are neglected or face adherence challenges. The company was founded by Tiffani Jones on March 31, 2016 and is headquartered in New York, NY. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Regnum Corp. engages in the business of developing and commercializing therapeutics that treat rare and infectious diseases. It focuses on populations that are neglected or face adherence challenges. The company was founded by Tiffani Jones on March 31, 2016 and is headquartered in New York, NY. |
| URL | N/A |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | |
| Industry | |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |